Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
The County of Santa Clara v. Astra USA, Inc et al
Case Number:
3:05-cv-03740
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Andrus Anderson
- Arnold & Porter
- Baker Donelson
- Dechert LLP
- Faegre Drinker
- Fox Rothschild
- GCA Law Partners
- Gordon Rees
- Hogan Lovells
- Jones Day
- King & Spalding
- Littler Mendelson
- McManis Faulkner
- Morgan Lewis
- Morrill Law Firm
- Pillsbury Winthrop
- Reed Smith
- Robbins Geller
- Ropes & Gray
- Scott&Scott
- Sedgwick LLP
- Shook Hardy
- Sidley Austin
Companies
- AstraZeneca PLC
- Bayer AG
- Bristol-Myers Squibb Co.
- Cardinal Health Inc.
- Cencora Inc.
- McKesson Corp.
- Merck & Co. Inc.
- Pfizer Inc.
Sectors & Industries:
-
February 28, 2012
Bayer, Others Exit Price-Fixing Suit After High Court Win
A California county on Monday settled its proposed class action accusing 11 drug companies of violating a federal pricing agreement by overcharging clinics serving the poor, nearly a year after the U.S. Supreme Court ruled that only the federal government can enforce such agreements.
-
June 03, 2011
Calif. County Seeks To Give US Drug Price-Fixing Docs
A California county sought permission Thursday to hand the U.S. evidence uncovered in a proposed class action — tossed by the U.S. Supreme Court in March — claiming major drugmakers violated pricing agreements with the federal government by overcharging clinics serving the poor.